Red Blood Cell Transfusion in the Intensive Care Unit
- PMID: 37824112
- PMCID: PMC10570913
- DOI: 10.1001/jama.2023.20737
Red Blood Cell Transfusion in the Intensive Care Unit
Erratum in
-
Nonauthor Collaborator Name Shown Incorrectly.JAMA. 2024 Aug 6;332(5):428. doi: 10.1001/jama.2024.12247. JAMA. 2024. PMID: 38976278 Free PMC article. No abstract available.
Abstract
Importance: Red blood cell (RBC) transfusion is common among patients admitted to the intensive care unit (ICU). Despite multiple randomized clinical trials of hemoglobin (Hb) thresholds for transfusion, little is known about how these thresholds are incorporated into current practice.
Objective: To evaluate and describe ICU RBC transfusion practices worldwide.
Design, setting, and participants: International, prospective, cohort study that involved 3643 adult patients from 233 ICUs in 30 countries on 6 continents from March 2019 to October 2022 with data collection in prespecified weeks.
Exposure: ICU stay.
Main outcomes and measures: The primary outcome was the occurrence of RBC transfusion during ICU stay. Additional outcomes included the indication(s) for RBC transfusion (consisting of clinical reasons and physiological triggers), the stated Hb threshold and actual measured Hb values before and after an RBC transfusion, and the number of units transfused.
Results: Among 3908 potentially eligible patients, 3643 were included across 233 ICUs (median of 11 patients per ICU [IQR, 5-20]) in 30 countries on 6 continents. Among the participants, the mean (SD) age was 61 (16) years, 62% were male (2267/3643), and the median Sequential Organ Failure Assessment score was 3.2 (IQR, 1.5-6.0). A total of 894 patients (25%) received 1 or more RBC transfusions during their ICU stay, with a median total of 2 units per patient (IQR, 1-4). The proportion of patients who received a transfusion ranged from 0% to 100% across centers, from 0% to 80% across countries, and from 19% to 45% across continents. Among the patients who received a transfusion, a total of 1727 RBC transfusions were administered, wherein the most common clinical indications were low Hb value (n = 1412 [81.8%]; mean [SD] lowest Hb before transfusion, 7.4 [1.2] g/dL), active bleeding (n = 479; 27.7%), and hemodynamic instability (n = 406 [23.5%]). Among the events with a stated physiological trigger, the most frequently stated triggers were hypotension (n = 728 [42.2%]), tachycardia (n = 474 [27.4%]), and increased lactate levels (n = 308 [17.8%]). The median lowest Hb level on days with an RBC transfusion ranged from 5.2 g/dL to 13.1 g/dL across centers, from 5.3 g/dL to 9.1 g/dL across countries, and from 7.2 g/dL to 8.7 g/dL across continents. Approximately 84% of ICUs administered transfusions to patients at a median Hb level greater than 7 g/dL.
Conclusions and relevance: RBC transfusion was common in patients admitted to ICUs worldwide between 2019 and 2022, with high variability across centers in transfusion practices.
Conflict of interest statement
Figures
Similar articles
-
The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.Crit Care Med. 2004 Jan;32(1):39-52. doi: 10.1097/01.CCM.0000104112.34142.79. Crit Care Med. 2004. PMID: 14707558
-
Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023.JAMA Netw Open. 2024 Sep 3;7(9):e2434077. doi: 10.1001/jamanetworkopen.2024.34077. JAMA Netw Open. 2024. PMID: 39298172 Free PMC article.
-
Transfusion thresholds for guiding red blood cell transfusion.Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD002042. doi: 10.1002/14651858.CD002042.pub5. Cochrane Database Syst Rev. 2021. PMID: 34932836 Free PMC article. Review.
-
Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care: The STRATUS Randomized Clinical Trial.JAMA. 2023 Nov 21;330(19):1872-1881. doi: 10.1001/jama.2023.20820. JAMA. 2023. PMID: 37824152 Free PMC article. Clinical Trial.
-
Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.Dan Med J. 2016 Feb;63(2):B5209. Dan Med J. 2016. PMID: 26836806 Review.
Cited by
-
Restrictive vs Liberal Transfusion Strategy in Patients With Acute Brain Injury: The TRAIN Randomized Clinical Trial.JAMA. 2024 Nov 19;332(19):1623-1633. doi: 10.1001/jama.2024.20424. JAMA. 2024. PMID: 39382241 Clinical Trial.
-
A Contemporary Review of Blood Transfusion in Critically Ill Patients.Medicina (Kaunas). 2024 Jul 31;60(8):1247. doi: 10.3390/medicina60081247. Medicina (Kaunas). 2024. PMID: 39202529 Free PMC article. Review.
-
Haemoglobin values, transfusion practices, and long-term outcomes in critically ill patients with traumatic brain injury: a secondary analysis of CENTER-TBI.Crit Care. 2024 Jun 14;28(1):199. doi: 10.1186/s13054-024-04980-6. Crit Care. 2024. PMID: 38877571 Free PMC article.
-
Blood Transfusion Procedure: Assessment of Serbian Intensive Care Nurses' Knowledge.Healthcare (Basel). 2024 Mar 25;12(7):720. doi: 10.3390/healthcare12070720. Healthcare (Basel). 2024. PMID: 38610143 Free PMC article.
-
A novel measure to summarize blood transfusion practice during critical illness.Transfusion. 2024 May;64(5):784-788. doi: 10.1111/trf.17814. Epub 2024 Mar 22. Transfusion. 2024. PMID: 38515390
References
-
- Free RJ, Sapiano MRP, Chavez Ortiz JL, Stewart P, Berger J, Basavaraju SV. Continued stabilization of blood collections and transfusions in the United States: findings from the 2021 National Blood Collection and Utilization Survey. Transfusion. 2023;(January):1-11. doi:10.1111/trf.17360 - DOI - PMC - PubMed
-
- Ducrocq G, Gonzalez-Juanatey JR, Puymirat E, et al. ; REALITY Investigators . Effect of a restrictive vs liberal blood transfusion strategy on major cardiovascular events among patients with acute myocardial infarction and anemia: the REALITY randomized clinical trial. JAMA. 2021;325(6):552-560. doi:10.1001/jama.2021.0135 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
